Jaime O. Claudio
Toronto, ON M5G2M9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Impact of High-Risk Mutations and Treatment Intensity in Accelerated-Phase Blast-Phase MPN Without Adverse-Risk Karyotype and TP53.
Journal: Current oncology (Toronto, Ont.)
Published: May 05, 2026
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences.
Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique
Published: September 02, 2025
Title Not Found
Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique
Published: August 28, 2025
Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving.
Journal: Canadian oncology nursing journal = Revue canadienne de nursing oncologique
Published: August 28, 2025
Clinical and molecular correlates of JAK-inhibitor therapy failure in myelofibrosis: long-term data from a molecularly annotated cohort.
Journal: Leukemia
Published: December 18, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study.
Journal: British journal of haematology
Published: March 28, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
Journal: Transplantation and cellular therapy
Published: January 05, 2021
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia.
Journal: Haematologica
Published: August 20, 2019
AML refractory to primary induction with Ida-FLAG has a poor clinical outcome.
Journal: Leukemia research
Published: January 19, 2018
Last Updated: 09/26/2026